Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides
Abstract
We evaluated the impact of applying the Infectious Diseases Society of America guidelines for febrile neutropenic patients in reducing the use of glycopeptides. Forty-five prior episodes of febrile neutropenia were compared to 97 episodes seen after application of the guidelines. Glycopeptide use wa …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
Teaching
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
male
adolescent
aged
middle aged
Child
hospitals
drug therapy
fever / drug therapy*
neutropenia / drug therapy*
anti-bacterial agents / therapeutic use*
combination / therapeutic use*
fever / complications
neutropenia / complications
brazil
vancomycin / therapeutic use
practice guidelines as topic*
cefepime
cephalosporins / administration & dosage
ceftazidime / therapeutic use
pmid:11776354
doi:10.1086/501839
m nucci
m landau
w pulcheri
amikacin / therapeutic use
oxacillin / administration & dosage
teicoplanin / therapeutic use
Access
Citation
ID:
119175
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
119175
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet